Alerts
PDF
Other content recommended for you
- Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials
- Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials
- Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China
- Sociodemographic and psychological characteristics influencing patients’ willingness to participate in clinical trials
- Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?
- Phase I oncology trials: why the therapeutic misconception will not go away
- Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015
- Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
- Informed consent as an ethical requirement in clinical trials: an old, but still unresolved issue. An observational study to evaluate patient's informed consent comprehension
- Perspectives of people with inherited retinal diseases on ocular gene therapy in Australia: protocol for a national survey